Jpmorgan Chase & Co - 31 Dec 2024 SCHEDULE 13G Report for Radiopharm Theranostics Limited Ordinary Shares, as represented by American Depositary Shares

Filing Manager: Jpmorgan Chase & Co
Reporting Manager: JPMORGAN CHASE & CO.
Security: Radiopharm Theranostics Limited Ordinary Shares, as represented by American Depositary Shares
Shares outstanding: 2.26B shares
Disclosed Ownership: 231M shares
Ownership: 10.2%
Form type: SCHEDULE 13G
Filing time: 11 Feb 2025, 12:16:38
Date of event: 31 Dec 2024
Next filing: 16 Jul 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
JPMORGAN CHASE & CO.	10.2%	231M	231M	0	Rachel Tsvaygoft	Vice President